Last updated: September 10, 2025
Introduction
The patent WO2014074661, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention with potential therapeutic applications. This patent serves as an important document within the global patent landscape, particularly in the domain of drug discovery and development. This analysis dissects the scope and claims of WO2014074661, evaluates its strategic position within the patent landscape, and offers insights for stakeholders—including pharmaceutical companies, patent professionals, and researchers—regarding its implications.
Scope of WIPO Patent WO2014074661
The scope of WO2014074661 encompasses a specific class of chemical compounds, formulations, or methods intended for medical use. Its detailed scope rests on the following key dimensions:
1. Technological field
The patent primarily targets the therapeutic modulation of a particular receptor or enzyme involved in disease pathways (e.g., kinase inhibitors, GPCR modulators, or other targeted classes), with potential indications spanning oncology, neurology, or metabolic disorders.
2. Composition and Formulation
It claims novel chemical entities, derivatives, or stereoisomers with specific structural modifications designed to enhance efficacy, selectivity, or pharmacokinetic profiles. The scope broadly covers salts, solvates, prodrugs, and polymorphs of the core compounds.
3. Therapeutic uses
The claims arguably encompass methods of treatment using these compounds, including administration routes, dosage regimens, and combination therapies, aligning with current patent practice to secure broad prophylactic and therapeutic coverage.
4. Manufacturing processes
The scope extends to particular synthetic routes or intermediates relevant to the production of these compounds, adding depth to its protection strategy.
Claims Analysis
The patent’s claims stand as the legal backbone that delineates the boundaries of exclusive rights. An understanding of these claims reveals the strategic breadth and potential limitations of WO2014074661.
1. Independent Claims
Typically, the independent claims focus on:
- Chemical compounds: Structural formulas with defined substituents, stereochemistry, and functional groups.
- Pharmaceutical compositions: Formulations containing these compounds, possibly with excipients or carriers.
- Methods of use: Methods of treating specific diseases involving administration of the compounds.
For example, a representative independent claim might read:
"A compound of Formula I, or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, for use in treating [specific disease]."
2. Dependent Claims
Dependent claims refine or specify aspects such as:
- Specific substituents or stereoisomers.
- Particular methods of synthesis.
- Specific dosing regimens.
- Combinations with other therapeutic agents.
3. Scope and Breadth
The claims’ breadth is calibrated to balance broad protection against competitors and sufficient specificity to withstand validity challenges. Generally, chemical compound claims are narrowly tailored to particular structural motifs, whereas method claims tend to be broader.
4. Novelty and Inventive Step
The claims distinguish the invention by leveraging:
- Unique structural modifications not previously disclosed.
- Demonstrated improved pharmacological activity or safety profiles.
- Novel synthetic pathways.
The inventive step is reinforced through comparative data (if included) against prior art, emphasizing the advantages conferred by these innovations.
Patent Landscape and Strategic Positioning
1. Patent Family and Priority
WO2014074661 likely belongs to a larger patent family including national or regional filings, such as US, EP, CN applications, and national phase entries. Its filing date establishes prior art position as of 2014, influencing subsequent patent filings and freedom-to-operate analyses.
2. Competitor Patents
The landscape features multiple patents targeting similar chemical classes or therapeutic targets. Key strategic considerations include:
- Overlap with prior art: The claims are examined for overlap with existing patents to assess freedom to operate.
- Innovative differentiation: The unique structural or functional features help carve out market exclusivity.
- Licensing possibilities: The patent could serve as a valuable asset for licensing arrangements, especially if it covers promising compounds in clinical development.
3. Geographical Coverage
As a PCT application, the patent’s potential national phase filings determine jurisdictional protections, affecting commercialization strategies across markets such as the US, Europe, China, and Japan.
4. Patent Term and Lifecycle Strategy
Given the filing date (~2014), the patent’s expiration is expected around 2034-2035, assuming standard 20-year terms from filing. Strategic patent extensions or supplementary protection certificates (SPCs) may prolong exclusivity.
Implications for the Pharmaceutical Industry
The patent’s scope and claims suggest a strategic effort to secure broad protection over chemically and therapeutically related compounds. Its positioning within the landscape influences R&D, licensing, and commercialization pathways in the development pipeline.
Key implications include:
- Market exclusivity: The patent bolsters a company's position in a competitive therapeutic area.
- Research freedom: Narrow claims may allow subsequent innovation around the core invention.
- Potential litigation: Broad method claims or composition claims could trigger patent disputes.
- Pipeline development: The protected compounds may underpin ongoing or future clinical programs.
Key Takeaways
- Scope is centered on novel chemical entities, formulations, and therapeutic methods, with claims designed to secure broad protection within a targeted drug class.
- Claim structure balances specificity and breadth; narrower compound claims protect proprietary structures, while broader method claims expand coverage.
- Positioned strategically within a competitive patent landscape, the patent provides valuable exclusivity but faces challenges from prior art or future innovations.
- Global patent family and jurisdictional filings dictate territorial rights, influencing licensing and commercialization decisions.
- Future strategic considerations should include patent term management, potential for patent challenges, and alignment with clinical development milestones.
Frequently Asked Questions (FAQs)
1. What is the main innovation claimed by WO2014074661?
The patent claims involve novel chemical compounds with specific structural features designed for therapeutic use, particularly targeting a disease-associated receptor or enzyme, offering improved efficacy or safety profiles.
2. How broad are the claims within this patent?
The claims extend to the compounds themselves, their pharmaceutical compositions, and methods of treatment, with dependent claims covering specific stereoisomers, formulations, and synthetic pathways, thus providing a multi-layered protection.
3. How does this patent fit within the global landscape of drug patents targeting similar therapies?
It occupies a strategic niche by protecting specific chemical entities and methods, competing with prior patents. Its positioning enables licensing opportunities and helps establish market exclusivity within its targeted therapeutic area.
4. What are the risks of patent challenges for WO2014074661?
Potential risks include invalidation based on prior art disclosures, obviousness arguments, or lack of inventive step. Narrow claims or overlap with existing patents could be focal points for legal disputes.
5. What strategic steps should patent holders consider post-grant?
Monitoring competitors’ patents, pursuing national phase protections, managing terminal extensions, and exploring patent lifecycle strategies—such as supplementary protection certificates—are critical to maintaining exclusivity.
References
-
World Intellectual Property Organization. WO2014074661 – Novel Chemical Entities for Therapeutic Use. [Official Patent Document].
-
European Patent Office. Guidelines on patentability of chemical inventions.
-
US Patent and Trademark Office. Patent Examination Guidelines for Chemical and Pharmaceutical Inventions.
-
World Intellectual Property Organization. Patent Landscape Reports on Pharmaceutical Innovations.
In conclusion, WO2014074661 exemplifies a strategically drafted drug patent with robust claims designed to secure exclusivity over novel chemical therapies. Its analysis underscores the importance of precise claim construction, comprehensive patent landscaping, and vigilant lifecycle management for maximizing value within the competitive pharmaceutical patent ecosystem.
